Home » Topics » BioWorld Science

BioWorld Science
RSS

HEXAPharmatec discovers new catechol derivatives

Feb. 7, 2020

Cav3.2 blockers patented by Nippon Chemiphar and Kindai University

Feb. 7, 2020

Janssen Biotech describes new STING agonists

Feb. 7, 2020

AVETUX trial shows potential of avelumab and cetuximab with FOLFOX in colorectal cancer

Feb. 7, 2020

Tau keeps gliomas in check

Feb. 7, 2020

Atreca and Merck & Co. collaborate to identify antibody targets in oncology

Feb. 6, 2020

Arthrosi begins phase IIa study of AR-882 for gout

Feb. 6, 2020

BiondVax reports preliminary phase II data on M-001 universal influenza vaccine candidate

Feb. 6, 2020

Antitumor activity seen with pembrolizumab in advanced anal squamous cell carcinoma trial

Feb. 6, 2020

Tonix stops enrollment in phase III PTSD study of Tonmya for futility

Feb. 6, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...